Der Kampf der Ratings

Bisher litt die deutsche Zertifikatbranche unter mangelnder Transparenz, aber jetzt könnte ein neues Ratingsystem den Investoren dringend benötigte Klarheit liefern. Wietske Blees berichtet

p11-livonius-jpg

Ein neues, auf Verbesserung der Transparenz des regen, aber komplexen deutschen Zertifikatmarkts ausgerichtetes Ratingsystem wird die Branche für strukturierte Produkte in Deutschland verändern. Die Investoren werden die Initiative wohl begrüßen, denn da ein qualitatives Ratingsystem bisher fehlte, konnten sie die Vor- und Nachteile der über 300.000 verfügbaren Zertifikate nur schwierig einschätzen.

"Der deutsche Zertifikatmarkt zählt zu den weltweit größten Märkten für derivative Produkte. Der

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

The new rules of market risk management

Amid 2020’s Covid-19-related market turmoil – with volatility and value-at-risk (VAR) measures soaring – some of the world’s largest investment banks took advantage of the extraordinary conditions to notch up record trading revenues. In a recent Risk.net…

ETF strategies to manage market volatility

Money managers and institutional investors are re-evaluating investment strategies in the face of rapidly shifting market conditions. Consequently, selective genres of exchange-traded funds (ETFs) are seeing robust growth in assets. Hong Kong Exchanges…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here